Overview / Abstract: |
Target Audience Program Overview This educational activity is an archive of the live virtual symposium held on June 4, 2021. Learning Objectives Determine the rationale underlying the use of antibody-drug conjugates in solid tumors |
Expiration |
Jun 15, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
2.0 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Sara A. Hurvitz, MD, FACP |
Sponsors / Supporters / Grant Providers |
AstraZeneca and Daiichi Sankyo, Inc. |
Keywords / Search Terms |
Relias LLC Relias, Free CME, Tumors, Antibody-Drug Free CE CME |